Through the Global Vaccine and Immunization Research Forum (GVIRF) collaboration, NIAID, the Bill & Melinda Gates Foundation, and WHO are organizing a webinar to showcase the challenges and lessons learned from development and deployment of a vaccine against a pathogen with complicated biology and without a dual market, and will involve discussion of strategies and considerations for future malaria vaccine research and development.
The webinar will take place on the 3rd of March 2022 from 9 am-12 pm EDT. For more information and to register please click the link below, the agenda can be found here.